FIFTH THIRD BANCORP - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 48 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 2.6%.

Quarter-by-quarter ownership
FIFTH THIRD BANCORP ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$12,000
+9.1%
1,4900.0%0.00%
Q3 2019$11,000
-35.3%
1,4900.0%0.00%
Q2 2019$17,000
+6.2%
1,4900.0%0.00%
Q1 2019$16,000
-27.3%
1,4900.0%0.00%
Q4 2018$22,000
-21.4%
1,4900.0%0.00%
Q3 2018$28,000
-17.6%
1,4900.0%0.00%
Q2 2018$34,000
-19.0%
1,4900.0%0.00%
Q1 2018$42,000
+35.5%
1,4900.0%0.00%
Q4 2017$31,000
+14.8%
1,4900.0%0.00%
Q3 2017$27,000
+17.4%
1,4900.0%0.00%
Q2 2017$23,000
-11.5%
1,4900.0%0.00%
Q1 2017$26,000
+62.5%
1,4900.0%0.00%
Q4 2016$16,000
-30.4%
1,4900.0%0.00%
Q3 2016$23,000
+53.3%
1,4900.0%0.00%
Q2 2016$15,000
+50.0%
1,490
+101.4%
0.00%
Q1 2016$10,000
-33.3%
7400.0%0.00%
Q4 2015$15,0007400.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
BVF INC/IL 5,576,471$36,526,0001.44%
Altium Capital Management LP 273,703$1,793,0000.67%
Jackson Creek Investment Advisors LLC 80,367$526,0000.21%
HARBOURVEST PARTNERS LLC 79,193$519,0000.20%
XTX MARKETS LLC 14,169$93,0000.19%
Perceptive Advisors 2,577,043$16,880,0000.18%
RTW INVESTMENTS, LP 1,527,352$10,004,0000.17%
Exane Asset Management 30,568$200,220,0000.14%
Virtus ETF Advisers LLC 37,343$245,0000.10%
Congress Park Capital LLC 25,807$169,0000.10%
View complete list of CYTOMX THERAPEUTICS INC shareholders